Gumokimab (AK 111), a monoclonal antibody, targets IL-17A and is utilized in researching psoriasis and ankylosing spondylitis. It competitively inhibits the interaction between human IL-17A and its receptor, IL-17R.
CAS Number:
[2428381-52-4]
* VAT and and shipping costs not included. Errors and price changes excepted